| Financial Year |
March 31 2023 |
| Monetary Funds |
242,605,723.35 |
| Held-for-trading Financial Assets |
50,000,000.00 |
| Notes Receivable |
13,534,692.28 |
| Accounts Receivable |
154,045,734.87 |
| Advances to Suppliers |
115,443,903.42 |
| Other Receivables |
43,176,711.42 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
2,000,000.00 |
| Inventories |
340,730,827.31 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
67,962,895.93 |
| Total Current Assets |
1,027,500,488.58 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
52,048,009.81 |
| Investment Properties |
-- |
| Fixed Assetes |
252,612,406.69 |
| Under-construction Projects |
5,138,775.69 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
720,191.85 |
| R&D expenses |
-- |
| Goodwill |
9,147,183.44 |
| Long-Term Deferred and Prepaid Expenses |
147,420,458.33 |
| Deferred Income Tax Assets |
2,512,974.30 |
| Other Non-Current Assets |
22,586,660.00 |
| Sub-Total of Non-Current Assets |
1,697,274,355.13 |
| Total Assets |
2,724,774,843.71 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
192,474,821.19 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
4,401,796.23 |
| Taxes Payable |
2,277,470.53 |
| Interest Payable |
151,029,324.28 |
| Dividend Payable |
-- |
| Other payables |
717,054,033.27 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
109,731,589.84 |
| Other Current Liabilities |
7,968,467.28 |
| Sub-Total of Current Liabilities |
1,272,977,358.12 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
2,025,708.11 |
| Special Payable |
-- |
| Estimatied Liabilities |
13,000,437.93 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,324,430,888.35 |
| Total Liabilities |
2,597,408,246.47 |
| Paid-In Capital(Or Share Stock) |
372,608,054.00 |
| Capital Surplus |
859,968,581.35 |
| Surplus Reserve |
37,893,762.94 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-1,049,593,645.85 |
| Minority Stockholder's Interest |
-93,153,823.57 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
220,520,420.81 |
| Owner's Equity（Stockholder's Equity） |
127,366,597.24 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,724,774,843.71 |
